Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Expression of Notch Pathway Components in Primary Samples of Allogeneic Hematopoietic Cell Transplant Patients with Chronic Graft Versus Host Disease

Marcos Paulo Colella, MD, Fernanda Soares Niemann, MSc, Beatriz Corey Morini, Matheus Lopes, PhD, Francisco José Penteado Aranha, MD PhD, Afonso Celso Vigorito, MD PhD, Sara T Olalla Saad, PhD, Patricia Favaro, PhD

Blood (2019) 134 (Supplement_1): 5600.

https://doi.org/10.1182/blood-2019-128785

Published: 2019

Journal Articles

Revisiting Old Practices: More Restricted Indication of Preoperative Autologous Blood Donation in Healthy Bone Marrow Donors According to Baseline Hemoglobin Levels

Isadora Olenscki Gilli, Afonso Celso Vigorito, MD PhD, Bruno Deltreggia Benites, MD

Blood (2018) 132 (Supplement 1): 3819.

https://doi.org/10.1182/blood-2018-99-111858

Published: 2018

Journal Articles

Vinorelbine-Based Hematopoietic Stem-Cell Mobilization: A More Effective, Low-Cost Alternative to Conventional Chemotherapy

Bruno Kosa Lino Duarte, MD, Marcos Paulo Colella, MD MSc, Fernando Vieira Pericole Souza, MD PhD, Gabriela G Yamaguti-Hayakawa, MD, Jose Francisco Comenalli Marques, Jr., MD PhD, Afonso Celso Vigorito, MD PhD, Erich Vinicius De Paula, MD PhD, Margareth C Ozelo, MD PhD

Blood (2018) 132 (Supplement 1): 4762.

https://doi.org/10.1182/blood-2018-99-119884

Published: 2018

Journal Articles

Pre-Transplant Beta2-Microglobulin Is an Independent Biomarker of Acute Graft-Versus-Host-Disease after Allogeneic Hematopoietic Cell Transplant in a Single Institutional Study

Carolina Costa-Lima, MD, Eliana Cristina Martins Miranda, PhD, Marcos Paulo Colella, MD, Francisco José Penteado Aranha, MD PhD, Carmino Antônio De Souza, MD PhD, Afonso Celso Vigorito, MD PhD, Erich Vinicius De Paula, MD PhD

Blood (2015) 126 (23): 3152.

https://doi.org/10.1182/blood.V126.23.3152.3152

Published: 2015

Journal Articles

Lack Of Advantage Of Peripheral Blood Hematopoietic Stem Cell Transplantation Over Bone Marrow From HLA Matched Related Donors After Myeloablative Conditioning For Hematologic Malignancies

Paulo Vidal Campregher, MD, Nelson Hamerschlak, MD, PhD, Vergilio Antonio Renzi Colturato, MD, Marcos Mauad, MD, Mair Pedro de Souza, MD, Luis Fernando S Bouzas, MD, PhD, Rita deCássia Barbosa Tavares, MD, Jose C. Barros, MD, Ricardo Chiattone, MD, Lisandra della Costa, MD, Lucia Silla, MD, PhD, Afonso Celso Vigorito, MD, PhD, Eliana C M Miranda, MEd, Vaneuza Araujo Moreira, MD, Mary E.D. Flowers, MD

Blood (2013) 122 (21): 5470.

https://doi.org/10.1182/blood.V122.21.5470.5470

Published: 2013

Journal Articles

The Utilization of NET Promoter System As a Blood Supply Management Strategy

Gustavo De Carvalho Duarte, MD, Erich V de Paula, MD, PhD, Francisco J P Aranha, MD, PhD, Gislaine Borba Oliveira, MD, Afonso Celso Vigorito, MD, PhD, Carmino Antonio De Souza, MD, PhD, José Francisco Marques, PhD

Blood (2012) 120 (21): 4378.

https://doi.org/10.1182/blood.V120.21.4378.4378

Published: 2012

Journal Articles

A High Angiopoietin-2/Angiopoietin-1 Ratio Independently Predicts Septic Shock Development in Patients with Chemotherapy-Associated Febrile Neutropenia and Hematological Malignancies.

Maiara Marx Luz Fiusa, Carolina Costa-Lima, MD, Gleice Regina Souza, Afonso Celso Vigorito, MD, PhD, Francisco J P Aranha, MD, PhD, Irene Lorand-Metze, MD, PhD, Joyce M Annichino-Bizzacchi, MD, PhD, Carmino Antonio De Souza, MD, PhD, Erich V De Paula, MD, PhD

Blood (2012) 120 (21): 2154.

https://doi.org/10.1182/blood.V120.21.2154.2154

Published: 2012

Journal Articles

Hematopoietic Cell Transplantation Co-Morbidity Index (HCT-CI) to Predict Non Relapse Mortality After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Marcos Paulo Colella, MD, Eliana C M Miranda, Francisco J. P Aranha, Md, Virginio C.A Fernandes-Junior, Md, Samuel de Souza Medina, MD, Carmino De Souza, MD, PhD, Afonso Celso Vigorito, MD, PhD

Blood (2011) 118 (21): 4561.

https://doi.org/10.1182/blood.V118.21.4561.4561

Published: 2011

Journal Articles

Cytomegalovirus (CMV) gB3 Genotype Is Associated with Acute Gvhd and CMV Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients (HSCT)

Débora de Campos Dieamant, MD, Sandra Helena Alves Bonon, PhD, Francisco J P Aranha, M.D., P.h.D., Gislaine O. Duarte, PhD, Virginio C.O. Fernandes, MD, Carmino Antonio De Souza, MD, PhD, Sandra Cecília Botelho Costa, PhD, Afonso Celso Vigorito, MD, PhD

Blood (2011) 118 (21): 1958.

https://doi.org/10.1182/blood.V118.21.1958.1958

Published: 2011

Journal Articles

Risk Factors for the Development of Acute and National Institute of Health (NIH) Chronic Graft-Versus-Host Disease (GVHD).

Mary E.D. Flowers, MD, Barry E. Storer, PhD, Stephanie J. Lee, MD, MPH, Paulo Vidal Campregher, MD, Afonso Celso Vigorito, MD, PhD, Paul A. Carpenter, MD, Marco Mielcarek, MD, Frederick R. Appelbaum, MD, Paul J. Martin, MD

Blood (2009) 114 (22): 345.

https://doi.org/10.1182/blood.V114.22.345.345

Published: 2009

NARROW

Expression of Notch Pathway Components in Primary Samples of Allogeneic Hematopoietic Cell Transplant Patients with Chronic Graft Versus Host Disease

Revisiting Old Practices: More Restricted Indication of Preoperative Autologous Blood Donation in Healthy Bone Marrow Donors According to Baseline Hemoglobin Levels

Vinorelbine-Based Hematopoietic Stem-Cell Mobilization: A More Effective, Low-Cost Alternative to Conventional Chemotherapy

Pre-Transplant Beta2-Microglobulin Is an Independent Biomarker of Acute Graft-Versus-Host-Disease after Allogeneic Hematopoietic Cell Transplant in a Single Institutional Study

Lack Of Advantage Of Peripheral Blood Hematopoietic Stem Cell Transplantation Over Bone Marrow From HLA Matched Related Donors After Myeloablative Conditioning For Hematologic Malignancies

The Utilization of NET Promoter System As a Blood Supply Management Strategy

A High Angiopoietin-2/Angiopoietin-1 Ratio Independently Predicts Septic Shock Development in Patients with Chemotherapy-Associated Febrile Neutropenia and Hematological Malignancies.

Hematopoietic Cell Transplantation Co-Morbidity Index (HCT-CI) to Predict Non Relapse Mortality After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Cytomegalovirus (CMV) gB3 Genotype Is Associated with Acute Gvhd and CMV Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients (HSCT)

Risk Factors for the Development of Acute and National Institute of Health (NIH) Chronic Graft-Versus-Host Disease (GVHD).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only